Holland scientists say they have found an alternative to antibiotics that could be used to combat viral infections such as resistant Staphylococcus aureus (MRSA).
Antibiotics have become a revolutionary invention in medicine of the XX century can fully belong to the past. This is due not only to their frequent and sometimes totally unjustified application but also to the rapid spread of infections that do not respond to new kinds of antibacterial drugs.
The problem has reached global scale over the past 10 years. Only in the United States insensitive to antibiotics infections claim the lives of 23000 people every year. But Holland researchers seem to give humanity a chance. Micreos biotech company developed the medicine that passed successful clinical trials in patients infected with Staphylococcus aureus (cases with eczema, contact dermatitis and other serious skin infections). The scientists have cured 5 of 6 patients suffering from extremely dangerous strains of bacteria exhibiting resistance even to powerful antibiotics.
A limited trial study conducted by a Dutch biotechnology company suggests that infection is unlikely to develop resistance to the new drug, an enzyme that attacks the bacteria.
Last year, an overall commission of health experts warned that strains of drug-resistant bacteria are one of the most serious threats ever faced by modern medicine.